Microscopes in California

Bio SB, Inc. is an FDA-registered and ISO 13485:2016 certified biotechnology manufacturer specializing in research, development, production, and distribution of antibodies and detection systems for molecular pathology. The company offers IVD validated monoclonal antibodies (rabbit and mouse), detection systems (ImmunoDetector, PolyDetector), and in situ hybridization technologies (FISH, CISH) for immunohistochemistry (IHC), immunocytochemistry (ICC), immunofluorescence (IF), and related diagnostic applications. Bio SB also manufactures automated staining equipment (TintoStainer Plus, TintoDetector) and tissue/cell line microarrays for cancer diagnostics, microbiology, immunology, and genetics research. The company serves biomedical laboratories, research institutions, and clinical settings globally, manufactured to FDA QSR 21 CFR Part 820 cGMP and CE IVD standards.

PathnSitu Biotechnologies is a specialized biotech manufacturer of immunohistochemistry (IHC) products and instruments for tissue-based cancer diagnosis. Founded in 2013 and based in California, the company produces a comprehensive portfolio including primary antibodies, detection kits, histology special stains, ancillary reagents, and automated staining instruments. Key product lines encompass the Caliber30 fully automated IHC staining system, tissue processors, microtomes, embedding centers, and digital scanning/microscopy solutions. The company also offers tissue microarray services and immunofluorescence reagents. PathnSitu serves pathology labs and cancer research centers with ISO 9001:2008 and ISO 13485:2003 certifications, adhering to USFDA, GMP, GDP, and GLP standards. The company emphasizes streamlined staining workflows, reduced turnaround times, and cost-effective solutions for accurate histology-based cancer diagnosis.

Shining 3D Technology Inc develops high-accuracy 3D optical scanning and measurement solutions for metrology, engineering, digital dentistry, and specialized industrial applications. The company manufactures laser scanners, blue light 3D scanners, and handheld wireless scanning devices serving precision inspection, quality assurance, automotive, aerospace, orthopedic implant manufacturing, and dental laboratory workflows. Product lines include entry-level scanners (EINSTAR series), professional all-in-one systems (EinScan Rigil Series with tri-mode laser capability), metrology-grade standalone scanners (FreeScan Omni Series), high-precision inspection systems (OptimScan Q12/Q9), and robotic automation solutions (RobotScan Series). Digital dentistry offerings include intraoral and extraoral scanning systems for prosthodontics and implant planning. The company operates a 1,100 m² CNAS-accredited calibration and accuracy laboratory staffed by certified metrologists, adhering to VDI/VDE and ISO international standards. Core competencies include high-accuracy optical calibration technology, opto-mechatronic system design, real-time stereo reconstruction algorithms, and 3D geometric data processing software with customizable inspection modules. Founded in 2004, the company has sold over 100,000 units globally and maintains a reseller and trade-in program. Recipients of Red Dot Design Award 2024/2026, iF Design Award 2022/2026, and recognition as an emerging leader in metrology. Target markets include automotive manufacturing, civil aviation MRO, marine/boatbuilding, motorsports, healthcare (orthotics/prosthetics), and educational institutions.

Diagnostic BioSystems Inc., founded in 1994, is a Pleasanton, California-based manufacturer of immunohistochemistry (IHC) reagents and anatomic pathology products for diagnostic and research applications. The company specializes in primary antibodies (IVD and RUO formulations for U.S. and international markets), detection systems (UnoVue™ HRP, PolyVue™ Plus HRP/DAB, Mohs™ HRP), chromogens, ancillary reagents (blockers, mounting media, buffers), and antigen retrieval solutions. DBS manufactures two proprietary automated staining instruments: the DBS HighLighter™ 360 autostainer (fully automated slide staining system) and Montage Opus365™ (antigen retrieval system). The product portfolio includes fluorescent antibodies (FITC, CF488), special stains, and accessory reagents for pathology labs. Recent product launches feature cancer-specific antibodies (CEACAM5, Uroplakin 3B, Claudin 18.2, NUT1, EGFR, CD117/c-kit, PSA). The company markets products both under IVD (in vitro diagnostic) and RUO (research use only) designations, with distribution through partnerships including Cardinal Health Scientific and ThermoFisher in the USA. DBS maintains regulatory compliance with FDA and international requirements (CE, SFDA approvals noted). The company serves anatomic pathology laboratories, cancer research institutions, and clinical diagnostic centers globally through direct sales and international distributor networks.

Antibodies Incorporated is a research-focused supplier of validated antibodies and assay reagents serving academic, biotech, and industrial research markets. The company aggregates products from multiple branded divisions: NeuroMab (primary monoclonal antibodies), Aves Labs (chicken polyclonal and recombinant chimeric antibodies), PhosphoSolutions (rabbit phosphospecific antibodies), ImmunoChemistry Technologies (cell viability assays, ELISA kits, IHC reagents), Biosensis (ELISA kits, antibodies, dyes, tracing reagents), and custom adenovirus production services. Product lines include primary and secondary antibodies, recombinant chimeric antibodies (newly expanded to chicken and guinea pig), phosphospecific antibodies for signaling research, ELISA kits and reagents, immunohistochemistry (IHC) products, cell viability and cytotoxicity assays, adenovirus reagents and custom virus production, and specialized research biochemicals. The company manufactures its products in-house and offers custom antibody development services, including a no-cost antibody production grant for academic and biotech researchers. Distribution is global through an established distributor network. All products are backed by a satisfaction guarantee with returns accepted.

Whittemore Enterprises, Inc. is a medical equipment distributor and liquidator operating since 1983 (42 years). The company specializes in veterinary surgical equipment, examination furniture, anesthesia systems, sterilization equipment, and surgical lighting. Primary product lines include Whittemore-branded veterinary anesthesia machines (table-mounted and wall-mount configurations), battery-operated and pneumatic TPLO (tibial plateau leveling osteotomy) surgical saws for orthopedic procedures, examination tables (Midmark/Ritter models), surgical ceiling lights (Startrol Galaxy high-output systems), and autoclaves (Tuttnauer TVET models). The company also carries surgical microscopes (ZEISS OPMI VARIO). Whittemore operates as a liquidator of medical equipment, explicitly stating pricing is 50-75% lower than OEM (original manufacturer) pricing. The company serves veterinary facilities and animal surgical centers. While the website indicates Synthes product liquidation, Whittemore clarifies it is not an authorized Synthes agent and does not provide Synthes warranties. The company maintains a B2B e-commerce platform for equipment sales and quotations. All products are sourced and resold; the company does not appear to manufacture equipment in-house.

Biocare Medical is a clinical pathology company specializing in immunohistochemistry (IHC), in situ hybridization (ISH), and fluorescence in situ hybridization (FISH) solutions for diagnostic and research laboratories. The company designs and manufactures an integrated platform of advanced staining instruments and over 300 optimized antibodies. Core product lines include the NeoPATH Pro, ONCORE Pro X, intelliPATH+, and intelliPATH MAX staining instruments, complemented by proprietary detection systems (MACH 4, MACH 3, MACH 2, MACH 1), multiplex IHC detection kits, and ancillary reagents (antigen retrieval solutions, enzymes, blocking reagents, mounting media, and wash buffers). The company also offers primary antibodies for various tissue types, FISH probes with copy control capabilities, RISH (RNA in situ hybridization) products, and animal tissue detection systems (PromARK). Biocare serves 50+ countries and maintains placements in over 1,000 clinical laboratories, including 95% of the top 50 cancer centers in the US. The company holds ISO 13485 certification and IVDR (In Vitro Diagnostic Regulation) certification for European markets. Technical support is available 24/7; customer service operates 6:30 AM–5:00 PM PST. Biocare was acquired by Agilent in 2024.

Applied Spectral Imaging (ASI) is a global leader in digital pathology and cytogenetics solutions with a three-decade legacy in biomedical imaging. The company develops computer-aided diagnostic software and imaging systems for brightfield, fluorescence, and spectral microscopy analysis. ASI serves clinical pathology and cytogenetic laboratories across 80+ countries through a network of distribution partners, including major academic medical centers (Cleveland Clinic, Duke, Montefiore). Core product lines include digital cytogenetics platforms for aided karyotyping and FISH (fluorescence in situ hybridization) scanning and analysis, and digital pathology solutions for H&E and immunohistochemistry (IHC) imaging with scanner-agnostic capabilities. Key software offerings include HiPath Pro for PD-L1 immunostaining interpretation and analysis, and metaphase finder/slide loader automation systems for increasing laboratory throughput and diagnostic accuracy. The company emphasizes integration of brightfield and fluorescence imaging modalities, tissue specimen matching, and user-centric design. ASI's solutions target improved inter- and intra-observer consistency, technologist productivity, and diagnostic confidence in cytogenetic and pathology workflows.

Compumedics Limited is a world-leading designer and manufacturer of diagnostic and research technologies for sleep, neurodiagnostics, brain research, and ultrasonic blood flow monitoring. Founded in 1987 and listed on the Australian Securities Exchange (ASX: CMP) since 2000, the company has established itself as a primary supplier of polysomnography (PSG) systems, EEG amplifiers and recorders, and magnetoencephalography (MEG) equipment. The product portfolio includes comprehensive sleep diagnostics solutions spanning in-lab, home-based, ambulatory, and wireless configurations, as well as complete neurodiagnostic platforms supporting clinical EEG, long-term monitoring (LTM), ICU continuous EEG (cEEG), and high-channel-count research applications. The company offers proprietary software platforms—Profusion Sleep, Profusion EEG, Profusion neXus 360 for laboratory management, and CURRY for advanced brain analytics—alongside supporting accessories and consumables. Compumedics operates a global infrastructure with corporate headquarters in Abbotsford, Australia, and major regional hubs in Charlotte, North Carolina (USA), Dresden and Freiberg (Germany), Strasbourg (France), and Shenzhen (China). The company maintains over 15% investment in R&D and holds a Medical Advisory Board to ensure continued innovation. Products are distributed globally to clinical institutions, research centers, and pharmaceutical organizations conducting clinical trials. Regulatory credentials and specific certifications are not detailed in the accessible content, though the company's long operational history and ASX listing indicate substantial compliance infrastructure.

Labo America (operating under the Labomed® brand) manufactures precision microscopes for medical, laboratory, and industrial applications. The company has operated for over 65 years and maintains a global presence with clients in more than 200 countries and approximately 1,500 employees worldwide. Their product portfolio includes dental operating microscopes (widely used in endodontics and surgical dentistry), medical microscopes for clinical diagnostics, ENT microscopes for otolaryngology procedures, laboratory microscopes for biotech and pharmaceutical research, and industrial microscopes. The company emphasizes optical precision through proprietary MaxLite Optics coating technology, ergonomic design, and competitive value pricing. Product lines feature zoom-focus capabilities, electromagnetic braking systems, LED illumination, and adjustable focal distances accommodating multiple users. Labomed microscopes are recognized for edge-to-edge optical sharpness and reliability in high-magnification clinical applications. The company provides local installation, customization services (including custom arm lengths to accommodate clinic layouts), and comprehensive service and support. While specific regulatory certifications (FDA, ISO, CE) are not detailed on the homepage, the company serves established dental practices, medical institutions, and research facilities globally, indicating compliance with relevant medical device standards.

ID-FISH Technology is a clinical laboratory diagnostics supplier specializing in fluorescence in situ hybridization (FISH) and ImmunoBlot testing technologies for the detection of tick-borne diseases and other pathogens. The company has over 15 years of experience developing diagnostic assays using patented FISH and ImmunoBlot methodologies. FISH technology detects and locates specific DNA sequences on chromosomes with greater sensitivity and specificity than traditional Giemsa-stained smear methods. ImmunoBlot tests determine the presence of pathogen-specific antibodies in patient serum or plasma using recombinant antigens, offering superior sensitivity and specificity compared to Western Blot or ELISA assays. The company's product portfolio includes FDA-cleared Lyme ImmunoBlot kits (iDart Lyme IgM and IgG), which feature 26 and 31 Lyme antigen bands respectively—more than competing immunoblot tests—and uniquely detect antibodies to Osp A (P31) and Osp B (P34) antigens. Products are designed for clinical laboratory use and meet FDA clearance requirements. The company serves clinical laboratory markets requiring sensitive, specific diagnostic testing capabilities for infectious disease detection.

Cision Vision is a medical technology company specializing in shortwave infrared (SWIR) imaging systems for pathology and surgical applications. Founded in 2020 as an MIT spinoff, the company's flagship InVision device provides label-free, real-time imaging that enhances lymph node identification and tissue grossing in laboratory and intraoperative settings. The technology leverages SWIR wavelengths (1000–2000 nm) to penetrate biological tissues deeply and provide natural contrast based on water and lipid content, eliminating the need for contrast agents or radiation. InVision has been recognized as one of Time Magazine's Best Inventions of 2023 and is deployed across multiple U.S. hospitals. The company's surgical application focuses on AI-powered critical structure identification during intraoperative guidance. Cision Vision has received significant government funding, including a prestigious ARPA-H award of up to $22.3 million as part of the Biden Cancer Moonshot initiative. The company collaborates with leading institutions including Johns Hopkins Medicine and Stanford Medicine, and operates the Visionary Program to support early-access initiatives for pathology innovators. Clinical validation includes a multicenter study published in the Journal of Clinical Pathology.